Organizing Committee

Charles Boucher, Chair
University Hospital Utrecht, The Netherlands

Brendan Larder, Chair
Visible Genetics, UK

Joep Lange
University of Amsterdam, The Netherlands

John Mellors
University of Pittsburgh, USA

Douglas Richman
University of California San Diego/VA Medical Center, USA

Scientific Committee

François Clavel
Hopital Bichat-Claude Bernard, France

Bonaventura Clotet
IRSI Caixa Foundation, Spain

John Coffin
NCI-FCRDC, USA

Richard Colonno
Bristol-Myers Squibb Company, USA

Richard D'Aquila
Vanderbilt University Medical Center, USA

Erik de Clercq
Rega Institute for Medical Research, Belgium

Emilio Emini
Merck Research Laboratories, USA

John Erickson
Sequoia, USA

Andrew Hill
Roche Products Ltd, UK

Victoria Johnson
University of Alabama at Birmingham, USA

Dale Kempf
Abbott Laboratories, USA

Joerg-Peter Kleim
GlaxoSmithKline plc, UK

Daniel Kuritzkes
University of Colorado Health Sciences Center, USA

Thomas Merigan
Stanford University School of Medicine, USA

Amy Patick
PGRD, LaJolla/Agouron Pharmaceuticals, USA

Luc Perrin
University of Cantonal Hospital, Switzerland

Christos Petropoulos
ViroLogic, Inc, USA

Deenan Pillay
University of Birmingham, UK

Raymond Schinazi
Emory University/Veterans Affairs Medical Center, USA

Jonathan Schapiro
Stanford University, USA

John Sninsky
Celera Diagnostics, USA

Ronald Swanstrom
University of North Carolina, USA

Stefano Vella
Istituto Superiore di Sanitá, Italy

Mark Wainberg
McGill University AIDS Centre, Canada

Patrick Yeni
Hopital Bichat-Claude Bernard, France